Resistência aos medicamentos anti-tuberculose de cepas de Mycobacterium tuberculosis isoladas de pacientes atendidos em hospital geral de referência para tratamento de AIDS no Rio de Janeiro

BACKGROUND:Tuberculosis become important challenge to health care settings. Brazil has high prevalence of the disease and Rio de Janeiro has high incidence rates with 30% of cases notified at hospitals. OBJECTIVE: To evaluate prevalence of initial and acquired drug resistance at a general hospital, reference for aids treatment in Rio de Janeiro and to identify associated factors. METHODS: Mycobacterium tuberculosis strains from 165 patients were analyzed, between August 1996 and February 1998. RESULTS: Twenty per cent (33/165) were resistant to at least one drug; 13% (12/165) to isoniazid; 3.64% (6/165) to rifampin and 3.64% (6/165) to both. Among HIV seropositive subjects (52/165); 28.85% (15/52) were resistant to at least one drug. Acquired resistance occurred in 15.79% of 19 patients that mentioned previous antiTB treatment. Association statistically significant was found with non cavitation on X-ray in bivariate analyses (P=0.05). Eighty four patients refereed no previous treatment (NPT). Resistance to 1 or more drugs was found in 28.57% (24/84) of NPT patients. Association statistically significant with initial resistance was found with health care workers (P=0.004), unemployment (P=0.03), and diarrhea (P=0.01) in bivariate analyses. On multivariate analyses, health care workers (P=0.002) remained significantly associated with initial resistance. CONCLUSIONS: High resistance rates was found. It corroborates that hospitals needs attention for TB control especially which concerns to health care works infection.

[1]  Antonio Ledo Alves Cunha,et al.  Óbitos atribuídos à tuberculose no Estado do Rio de Janeiro , 2004 .

[2]  M. Conde,et al.  Defaulting from anti-tuberculosis treatment in a teaching hospital in Rio de Janeiro, Brazil. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[3]  A. Trajman,et al.  The study of tuberculosis-attributed deaths as a tool for disease control planning in Rio de Janeiro, Brazil. , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[4]  S. Natal Emergência da resistência às drogas , 2002 .

[5]  B. Polsky,et al.  Failure to Implement Respiratory Isolation: Why Does it Happen? , 2002, Infection Control & Hospital Epidemiology.

[6]  L. Brito Tuberculose nosocomial medidas de controle de engenharia , 2001 .

[7]  A. Kritski,et al.  The Tuberculosis Scientific League: enrolling medical students in the battle against the disease. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[8]  P. Small,et al.  Management of tuberculosis in the United States. , 2001, The New England journal of medicine.

[9]  Christopher Dye,et al.  Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. , 2001, The New England journal of medicine.

[10]  F. Chaimowicz Age transition of tuberculosis incidence and mortality in Brazil. , 2001, Revista de saude publica.

[11]  Cláudia Medina Coeli,et al.  Reclink: aplicativo para o relacionamento de bases de dados, implementando o método probabilistic record linkage , 2000 .

[12]  A. Harries,et al.  Screening tuberculosis suspects using two sputum smears. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[13]  C. Dye,et al.  Progress in global tuberculosis control 1995-1996, with emphasis on 22 high-incidence countries. Global Monitoring and Surveillance Project. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[14]  H L Rieder,et al.  Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. , 1998, The New England journal of medicine.

[15]  M. Aziz,et al.  Guidelines for surveillance of drug resistance in tuberculosis , 2009 .

[16]  D. Maher,et al.  Guidelines for the Management of Drug-resistant Tuberculosis , 1997 .

[17]  J. Mcgowan Nosocomial tuberculosis: new progress in control and prevention. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  W. Yew,et al.  Drug-resistant tuberculosis in the 1990s. , 1995, The European respiratory journal.

[19]  J. Mcgowan,et al.  Preventing the Nosocomial Transmission of Tuberculosis , 1995, Annals of Internal Medicine.

[20]  D. Snider,et al.  The neglected global tuberculosis problem: a report of the 1992 World Congress on Tuberculosis. , 1994, The Journal of infectious diseases.

[21]  M. Raviglione,et al.  Global tuberculosis incidence and mortality during 1990-2000. , 1994, Bulletin of the World Health Organization.

[22]  John E. Bennett,et al.  Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .